BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Inhibitex, Inc. 

1165 Sanctuary Parkway, Suite 400

Alpharetta  Georgia  30004  U.S.A.
Phone: 678-746-1100 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
Bristol-Myers Squibb Company (BMY) Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. (INHX) 2/13/2012 6:33:20 AM
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibitex, Inc. (INHX), in Connection with the Sale of the Company to Bristol-Myers Squibb Company (BMY) 1/11/2012 6:08:27 AM
Bristol-Myers Squibb Company (BMY) to Acquire Inhibitex, Inc. (INHX) for $2.5 Billion 1/9/2012 6:53:43 AM
Inhibitex, Inc. (INHX) to Participate in the 2011 Deutsche Bank (DB) BioFEST 12/2/2011 8:41:56 AM
Inhibitex, Inc. (INHX) Reports Recent Clinical and Corporate Developments 11/29/2011 9:57:39 AM
Inhibitex, Inc. (INHX) to Participate in Four Upcoming Investor Conferences 11/9/2011 8:12:17 AM
Inhibitex, Inc. (INHX) Reports Third Quarter Financial Results and Recent Corporate Developments 11/4/2011 7:02:10 AM
Inhibitex, Inc. (INHX) to Host Conference Call to Report Third Quarter Financial Results on November 4, 2011 10/27/2011 7:42:46 AM
Inhibitex, Inc. (INHX) Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients 9/19/2011 9:41:19 AM
Inhibitex, Inc. (INHX) to Present at Two Upcoming Conferences 8/26/2011 9:43:35 AM
12345678910...